{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:48:15Z","timestamp":1761976095981,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.hlc.2023.12.019","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T21:39:57Z","timestamp":1709242797000},"page":"524-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients"],"prefix":"10.1016","volume":"33","author":[{"given":"V\u00edctor M.","family":"Mora-Cuesta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaya","family":"Mart\u00ednez-Me\u00f1aca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-266X","authenticated-orcid":false,"given":"David","family":"Iturbe-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Tello-Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Izquierdo-Cuervo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4088-8310","authenticated-orcid":false,"given":"Tamara","family":"Garc\u00eda-Camarero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-048X","authenticated-orcid":false,"given":"Aritz","family":"Gil-Ongay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-3797","authenticated-orcid":false,"given":"Laura","family":"S\u00e1nchez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Alonso-Lecue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Naranjo-Gozalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Cifri\u00e1n-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2023.12.019_bib1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2023.12.019_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-2600(15)00517-2","article-title":"Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways","volume":"4","author":"Rowan","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.2003.009860","article-title":"Angiogenic cytokines in patients with idiopathic interstitial pneumonia","volume":"59","author":"Simler","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.hlc.2023.12.019_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1164\/rccm.200308-1111OC","article-title":"Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis","volume":"169","author":"Ebina","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1164\/rccm.200210-1233OC","article-title":"Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease","volume":"167","author":"Santos","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1164\/ajrccm.164.4.2101023","article-title":"Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers","volume":"164","author":"Barber\u00e0","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/rccm.200605-724OC","article-title":"Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke","volume":"175","author":"Nana-Sinkam","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A\u00a0randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2023.12.019_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/15412555.2011.651180","article-title":"Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial","volume":"9","author":"Lederer","year":"2012","journal-title":"COPD"},{"key":"10.1016\/j.hlc.2023.12.019_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.00176312","article-title":"Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial","volume":"42","author":"Blanco","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2023.12.019_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary hypertension Registry: survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/15412555.2017.1336209","article-title":"Admission for COPD exacerbation is associated with the clinical diagnosis of pulmonary hypertension: results from a retrospective longitudinal study of a veteran population","volume":"14","author":"Medrek","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.hlc.2023.12.019_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2021.02.012","article-title":"Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"160","author":"Vizza","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2023.12.019_bib16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2023.12.019_bib17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-022-02495-y","article-title":"Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization","volume":"22","author":"Abu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hlc.2023.12.019_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.healun.2017.07.021","article-title":"Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: definition and grading\u2014a 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation","volume":"36","author":"Snell","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib23","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.21037\/jtd-20-3564","article-title":"Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors","volume":"13","author":"Daoud","year":"2021","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.hlc.2023.12.019_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/TP.0000000000002220","article-title":"ISHLT primary graft dysfunction incidence, risk factors, and outcome: a UK national study","volume":"103","author":"Avtaar Singh","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.hlc.2023.12.019_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ccm.2017.07.005","article-title":"Primary graft dysfunction after lung transplantation","volume":"38","author":"Porteous","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1378\/chest.127.1.161","article-title":"Impact of primary graft failure on outcomes following lung transplantation","volume":"127","author":"Christie","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2023.12.019_bib27","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1164\/rccm.200409-1243OC","article-title":"The effect of primary graft dysfunction on survival after lung transplantation","volume":"171","author":"Christie","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2017.07.020","volume":"36","author":"Diamond","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.09-2806","article-title":"Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis","volume":"139","author":"Fang","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2023.12.019_bib31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1164\/rccm.201508-1522OC","article-title":"Diastolic dysfunction increases the risk of primary graft dysfunction after lung transplant","volume":"193","author":"Porteous","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2023.12.019_bib32","article-title":"Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2023.12.019_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13251","article-title":"Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation","volume":"32","author":"Cottini","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2023.12.019_bib35","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14832","article-title":"Early onset of azithromycin to prevent CLAD in lung transplantation: promising results of a retrospective single centre experience","volume":"37","author":"Cristeto Porras","year":"2023","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hlc.2023.12.019_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/13993003.00944-2021","article-title":"Elevated pulmonary vascular resistance predicts mortality in COPD patients","volume":"58","author":"Zeder","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2023.12.019_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01483-2021","article-title":"Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry","volume":"58","author":"Olsson","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:15:58Z","timestamp":1714608958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950624000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1443950624000374"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2023.12.019","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2023.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}